Clearside Biomedical Stock Analysis

Clearside Stock Analysis Notes

About 21.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 130.0. Clearside Biomedical recorded a loss per share of 0.53. The entity had not issued any dividends in recent years. Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people. For more info on Clearside Biomedical please contact JD PharmD at 678 270 3631 or go to https://clearsidebio.com.

Clearside Biomedical Investment Alerts

Clearside Biomedical Upcoming and Recent Events

Clearside Largest EPS Surprises

View All Earnings Estimates

Clearside Stock Institutional Investors

Note, although Clearside Biomedical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Clearside Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clearside Biomedical's market, we take the total number of its shares issued and multiply it by Clearside Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Clearside Profitablity

Management Efficiency

Clearside Biomedical has return on total asset (ROA) of (0.364) % which means that it has lost $0.364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.1002) %, meaning that it created substantial loss on money invested by shareholders. Clearside Biomedical's management efficiency ratios could be used to measure how well Clearside Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 2.14, whereas Return On Tangible Assets are forecasted to decline to (1.00). At present, Clearside Biomedical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.1 M, whereas Other Assets are forecasted to decline to 0.95.

Technical Drivers

As of the 18th of April 2024, Clearside Biomedical shows the risk adjusted performance of 0.004, and Mean Deviation of 3.98. Clearside Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for Clearside Biomedical, which can be compared to its peers. Please confirm Clearside Biomedical market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Clearside Biomedical is priced correctly, providing market reflects its regular price of 1.32 per share. Given that Clearside Biomedical is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Clearside Biomedical Price Movement Analysis

Clearside Biomedical Insider Trading Activities

Clearside Biomedical Predictive Daily Indicators

Clearside Biomedical Forecast Models

Clearside Biomedical's time-series forecasting models are one of many Clearside Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearside Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Clearside Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Clearside shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Clearside Biomedical. By using and applying Clearside Stock analysis, traders can create a robust methodology for identifying Clearside entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Clearside analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Clearside analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Clearside Biomedical stock analysis indicators help investors evaluate how Clearside Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Clearside Biomedical shares will generate the highest return on investment. By understating and applying Clearside Biomedical stock analysis, traders can identify Clearside Biomedical position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.

Is Clearside Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.